Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications Reinou S. GroenA. Wolter J. OosterhuisJames E. Boers Pre-clinical Study 13 January 2007 Pages: 1 - 5
RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer Y. S. LauL. DanksN. A. Athanasou PRECLINICAL STUDY 07 December 2006 Pages: 7 - 16
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer Hope RugoEmma ShtivelmanDebu Tripathy Critical Trial 17 November 2006 Pages: 17 - 28
Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells John Yoonkeun JunJames W. GriffithAndrea Manni Clinical Study 02 December 2006 Pages: 29 - 36
Minority report – false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis S. CiattoN. HoussamiM. Rosselli Del Turco Epidemiology 18 November 2006 Pages: 37 - 43
Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors Page E. AbrahamsonShelley S. TworogerAnne McTiernan Epidemiology 01 November 2006 Pages: 45 - 54
Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival Aesun ShinZefang RenWei Zheng Epidemiology 26 October 2006 Pages: 55 - 61
Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer N. van den BroekM. J. C. van der SangenA. C. Voogd EPIDEMILOGY 18 November 2006 Pages: 63 - 68
Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study Jane C. FigueiredoMarguerite EnnisPamela J. Goodwin Clinical Epidemiology 18 November 2006 Pages: 69 - 80
Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature Alberto LuiniGiovanna GattiGiuseppe Viale Original Paper 18 November 2006 Pages: 81 - 85
Serial 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP) Jennifer M. SpechtStephen L. TamDavid A. Mankoff Original Paper 01 February 2007 Pages: 87 - 94
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro E. BucciarelliA. SidoniA. Bellahcène Original Paper 30 November 2006 Pages: 95 - 104
Mid-region parathyroid hormone-related protein (PTHrP) binds chromatin of MDA-MB231 breast cancer cells and isolated oligonucleotides “in vitro” Rosalia SirchiaMarcella PriullaClaudio Luparello Original Paper 24 November 2006 Pages: 105 - 116